Marty Makary

Stealth CEO questions FDA rejection of rare disease drug

“We are kind of hanging on by our fingernails here to try to bring this drug to the patient community,” Stealth CEO Reenie McCarthy told Fierce Biotech.

Gabrielle Masson May 29, 2025 2:27pm